A Study to Evaluate the Effects of the Speed Sleep Supplement on Sleep Quality and Quantity

April 27, 2026 updated by: Bio Nature Health
This study evaluates the effects of the Speed Sleep supplement on sleep quality and quantity in adults aged 18-65 years. Participants will be randomized to receive either the supplement or placebo for 4 weeks, with outcomes assessed using Fitbit sleep tracking data and questionnaires.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Nevada
      • Las Vegas, Nevada, United States, 89118
        • Citruslabs

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Male or female
  • Aged 18-65
  • Experiencing issues with sleep (falling asleep, staying asleep)
  • Generally healthy
  • Willing to discontinue sleep-related supplements
  • Maintain consistent sleep patterns
  • Resides in the United States

Exclusion Criteria:

  • Chronic medical or sleep disorders
  • Use of sleep medications
  • Hormone therapy or anticoagulants
  • Heavy alcohol use
  • Night shift workers
  • Pregnancy or breastfeeding
  • Smoking or substance abuse
  • Allergies to ingredients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Speed Sleep Supplement
Participants receive Speed Sleep supplement daily for 4 weeks.
Dietary supplement: Dietary Supplement: Speed Sleep
Six capsules taken once daily 30 minutes before bedtime.
Placebo Comparator: Placebo
Participants receive placebo capsules daily for 4 weeks.
Dietary supplement: Placebo
Six rice flour capsules taken once daily 30 minutes before bedtime.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Sleep Score
Time Frame: Baseline and Week 4
Assessed using Fitbit-generated sleep score reflecting overall sleep quality. Higher scores indicate better sleep quality.
Baseline and Week 4
Change in Total Sleep Time
Time Frame: Baseline and Week 4
Measured using Fitbit as total time asleep during the night.
Baseline and Week 4
Change in Time Awake During Sleep Period
Time Frame: Baseline and Week 4
Measured using Fitbit as total time awake during the sleep period.
Baseline and Week 4
Change in Number of Awakenings
Time Frame: Baseline and Week 4
Measured using Fitbit as number of awakenings during the sleep period.
Baseline and Week 4
Change in Deep Sleep Duration
Time Frame: Baseline and Week 4
Measured using Fitbit as time spent in deep sleep stages.
Baseline and Week 4
Change in REM Sleep Duration
Time Frame: Baseline and Week 4
Measured using Fitbit as time spent in REM sleep stages.
Baseline and Week 4
Change in Sleep Quality Score (SQS)
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4
Assessed using the validated Sleep Quality Score (SQS) questionnaire. Scores reflect subjective sleep quality, with changes over time indicating improvement or decline.
Baseline, Week 1, Week 2, Week 3, Week 4

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Sleep Latency
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4
Assessed via questionnaire responses evaluating time required to fall asleep.
Baseline, Week 1, Week 2, Week 3, Week 4
Change in Self-Reported Anxiety Levels
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4
Assessed via questionnaire responses evaluating perceived anxiety related to sleep.
Baseline, Week 1, Week 2, Week 3, Week 4
Change in Self-Reported Level of Relaxation
Time Frame: Baseline, Week 1, Week 2, Week 3, Week 4
Assessed via questionnaire responses evaluating perceived relaxation before sleep.
Baseline, Week 1, Week 2, Week 3, Week 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bio Nature Health

Collaborators

Citruslabs

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 3, 2024

Primary Completion (Actual)

January 13, 2025

Study Completion (Actual)

January 13, 2025

Study Registration Dates

First Submitted

April 27, 2026

First Submitted That Met QC Criteria

April 27, 2026

First Posted (Actual)

May 4, 2026

Study Record Updates

Last Update Posted (Actual)

May 4, 2026

Last Update Submitted That Met QC Criteria

April 27, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20687

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sleep Disturbance

Clinical Trials on Dietary Supplement: Speed Sleep

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe